Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 63629-8319

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 63629-8319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 01

Chemical structure of Tramadol Hydrochloride shown with molecular framework including a methoxy-substituted aromatic ring, cyclohexanol group, and dimethylaminoethyl side chain, adjacent to hydrochloride notation (.HCl).*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 02

A pharmacokinetic curve showing tramadol concentration (ng/mL) over 24 hours. The graph compares Tramadol Hydrochloride Extended-Release Tablets, 200 mg once daily (q.d.), represented with filled circles, and Tramadol Hydrochloride Tablets, 50 mg every 6 hours (q6h), represented with open circles. The x-axis indicates time in hours, and the y-axis shows tramadol plasma concentration.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 03

A line graph depicting M1 concentration (ng/mL) over time (hours) comparing Tramadol Hydrochloride Extended-Release Tablets, 200 mg q.d. and Tramadol Hydrochloride Tablets, 50 mg q6h. The x-axis represents time in hours from 0 to 24 and the y-axis shows M1 concentration ranging from 0 to 120 ng/mL. Two lines with markers indicate drug concentration profiles through the 24-hour period.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 04

Line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis' showing the percent of patients achieving various levels of response threshold (percent improvement from baseline). The graph compares Tramadol Hydrochloride extended-release tablets at 100 mg, 200 mg, 300 mg, and 400 mg doses, and placebo. The percent of patients achieving response decreases as the response threshold increases for all groups.*

FDA Label Image

7848ebcb 7a13 48a8 Bbeb 7481d040c068 05

A line graph comparing the percentage of patients achieving various levels of response threshold in arthritis pain intensity between Tramadol Hydrochloride Extended-Release Tablets and placebo. The x-axis shows response thresholds as percent improvement from baseline, and the y-axis shows the percent of patients achieving response. Tramadol shows consistently higher patient response percentages than placebo across thresholds.*

FDA Label Image

Label Image (Lbl636298319)

Label for Tramadol ER 200 mg (CIV) extended release tablets packaged by Bryant Ranch Prepack, Burbank, CA. The label indicates a comparison to Ultram ER 200 mg tablets by Lupin Limited. The package contains 30 tablets with storage instructions at 20°-25°C (68°-77°F). The NDC number shown is 63629-8319-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.